11 – 20 of 753
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
IgA vasculitis nephritis - outcomes in adult-onset disease
(
- Contribution to journal › Article
-
Mark
Dose-Response Relationship of Phloretin Therapy on Water and Glucose Transport during Experimental Peritoneal Dialysis
2025) In Kidney360(
- Contribution to journal › Article
-
Mark
Efficacy and Safety of Rituximab in Antiglomerular Basement Membrane Disease
(
- Contribution to journal › Article
-
Mark
Will Xylocore® be the magic ELIXIR for peritoneal dialysis?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Revised free light chain reference intervals enhance risk stratification in monoclonal gammopathy of undetermined significance and reduce overdiagnosis
(
- Contribution to journal › Article
-
Mark
In-Depth Analysis of Disease Manifestations in Antineutrophil Cytoplasmic Antibody–Associated Vasculitides Identifies Distinct Clinical Phenotypes
(
- Contribution to journal › Article
-
Mark
New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance
(
- Contribution to journal › Article
-
Mark
Albuminuria predicts kidney events in IgA nephropathy
(
- Contribution to journal › Article
-
Mark
A clinical study of efficacy and safety of the Carry Life UF system in continuous ambulatory peritoneal dialysis patients : protocol for a prospective, multicenter, randomized, crossover study
(
- Contribution to journal › Article
- 2024
-
Mark
Using imlifidase to elucidate the characteristics and importance of anti-GBM antibodies produced after start of treatment
2024) In Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 39(1). p.45-54(
- Contribution to journal › Article